Achalasia: Outcome of Symptoms in Patients Undergoing a Heller Myotomy
Sponsor
University of South Florida (Other)
Overall Status
Unknown status
CT.gov ID
NCT00519220
Collaborator
(none)
800
1
132
6.1
Study Details
Study Description
Brief Summary
The objective of this study is to review studies and patient symptoms before and after laparoscopic Heller myotomy to assess outcomes following laparoscopic surgery for achalasia.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Patients will answer questionnaires before and after surgery to evaluate their symptoms of achalasia and will also have their charts reviewed for relevant medical information.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
800 participants
Official Title:
Short and Long Term Outcomes of Heller Myotomy
Study Start Date
:
Dec 1, 2006
Anticipated Study Completion Date
:
Dec 1, 2017
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
I Patients will answer symptom questionnaires and have their charts reviewed for relevant medical information. |
Other: Symptom questionnaire
Patients will answer questionnaires evaluating their symptoms of achalasia.
|
Outcome Measures
Primary Outcome Measures
- The objective of this study is to review pre-operative and post-operative studies and patient evaluation reports to evaluate patient outcomes following laparoscopic surgery for achalasia [5 years]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Patients with achalasia who have had laparoscopic Heller myotomies for the treatment of achalasia
Exclusion Criteria:
- No patients under the age of 18 will be included
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Tampa General Hospital/University of South Florida | Tampa | Florida | United States | 33606 |
Sponsors and Collaborators
- University of South Florida
Investigators
- Principal Investigator: Alexander S Rosemurgy, MD, University of South Florida
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Kenneth Luberice,
Principal Investigator,
University of South Florida
ClinicalTrials.gov Identifier:
NCT00519220
Other Study ID Numbers:
- 105235
First Posted:
Aug 22, 2007
Last Update Posted:
Aug 15, 2012
Last Verified:
Aug 1, 2012
Keywords provided by Kenneth Luberice,
Principal Investigator,
University of South Florida
Additional relevant MeSH terms: